Sanofi has added to its vaccine pipeline with an agreement to acquire Austria's Origimm Biotechnology and its vaccine-based immunotherapy for people with acne.
Sanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as the new chief executive of French specialty drugmaker Ipsen, taking over
Sanofi’s Pasteur vaccines unit has joined with the US biotech Translate Bio to announce a partnership to develop an mRNA vaccine against the coronavirus that causes the COVID-19 pandemic.
Regeneron has ended development of its antibody suptavumab after it failed to prevent respiratory syncytial virus (RSV) infections in babies in a phase 3 trial.
Seismic Therapeutic has raised $121 million in second-round financing that will be used to take its two lead drugs through early-stage clinical testing.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio